Everest Organics Limited has formally disclosed to BSE the reasons behind the delayed submission of its unaudited financial results for the quarter ended December 31, 2025, citing extended board deliberations and additional information requirements that prevented timely compliance with regulatory deadlines.

Regulatory Communication Details

The company submitted its explanation to BSE on March 06, 2026, in response to the exchange's email dated March 05, 2026, regarding non-compliance with Regulation 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication addressed the company's failure to submit results within the prescribed 45-day period and the subsequent delay in providing explanatory disclosures.

Board Meeting Timeline and Challenges

The company provided specific details about the circumstances that led to the delay:

The extended duration of the board meeting, involving detailed discussions that continued past midnight, contributed to the company's inability to meet the regulatory timeline. The board's requirement for additional information before finalizing the results further complicated the submission process.

Compliance Actions and Acknowledgments

Everest Organics confirmed that despite the delay in the initial submission timeline, the company uploaded both the Board Meeting outcome and unaudited financial results on the BSE Listing Portal immediately upon the meeting's conclusion on February 15, 2026. The submissions were made in both PDF and XBRL formats as required by regulations.

The company acknowledged its oversight in not submitting the detailed reasons for delay within one working day as prescribed by regulations. Management noted that February 15, 2026, being the day of results submission, was not a working day for the Stock Exchange, which contributed to the procedural complications.

Trading Window and Insider Trading Compliance

In accordance with SEBI (Prohibition of Insider Trading) Regulations, the company maintained proper trading window protocols. The trading window remained closed and was reopened after 48 hours from the declaration of the unaudited financial results, ensuring compliance with insider trading prevention measures.

Future Compliance Assurance

Everest Organics has provided assurance to BSE regarding improved compliance measures going forward. The company stated it will take necessary care to ensure timely submission of all required disclosures in future and confirmed that such oversights will not occur again. The management has requested BSE to take the explanation on record and condone the delay in submission of the required disclosure.

Everest Organics Limited has announced the approval of its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's Board of Directors convened on February 14, 2026, to review and approve the quarterly financial performance under Regulation 33 of the SEBI Listing Regulations.

Board Meeting Details

The board meeting was conducted on Saturday, February 14, 2026, with proceedings extending from 08:45 PM to 01:00 AM. The meeting was held in compliance with Regulation 29, 30, 33 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Approvals and Documentation

During the meeting, the Board of Directors approved and took on record two significant items:

Regulatory Compliance

The announcement was made pursuant to the SEBI Listing Regulations, ensuring full compliance with disclosure requirements. The communication was addressed to the Listing Compliance Department of BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai. Company Secretary and Compliance Officer Shweta Singh signed the official communication, which was digitally authenticated on February 15, 2026, at 01:06:27 +05'30'.

Information Accessibility

Everest Organics Limited has made the approved financial information available on its official website at www.everestorganicsltd.com , ensuring transparency and accessibility for stakeholders and investors. The company maintains its commitment to regulatory compliance and timely disclosure of material information to the stock exchanges.